Among a set of 1128 well-characterized FFPE NSCLC specimens, 10 and 13 samples with or without ALK fusion, respectively, were selected for NGS testing and results were compared to IHC and FISH. This evidence concerns the gene ALK and non-small cell lung carcinoma.